RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 DURATION-3 Trial Results
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 11
SP 15
OP 16
DO 10.1177/155989771311012
UL http://mdc.sagepub.com/content/13/11/15.abstract
AB Three-year data from the Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Metformin Alone or in Combination With Sulfonylurea trial [DURATION-3; NCT00641056] have confirmed previously reported 26- and 84-week results demonstrating the superiority of the exenatide regimen for glycemic and weight control, and lowered risk of hypoglycemia [Diamant M et al. Lancet 2010; Diamant M et al. Diabetes Care 2012].